That the House of Representatives— (1) applauds the tremendous growth in research and development into new therapies for rare diseases and the resulting number of FDA-approved therapies for people living with rare diseases; (2) recognizes that significant research and development efforts and related investments are needed to develop therapies to treat and cure the thousands of rare diseases for which no treatment options are currently available; and (3) affirms the need to continue supporting public and encouraging private investment in research and development of new treatments for rare diseases.